Showing 141 - 160 results of 597 for search '"prostate cancer"', query time: 0.07s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148

    High-Intensity Focused Ultrasound for Prostate Cancer: Long-Term Followup and Complications Rate by Umberto Maestroni, Francesco Dinale, Roberto Minari, Paolo Salsi, Francesco Ziglioli

    Published 2012-01-01
    “…As it is well known, High Intensity Focused Ultrasound (HIFU) is a minimally invasive procedure for prostate cancer. Many investigators reported their series of patients, demonstrating the effectiveness of the treatment. …”
    Get full text
    Article
  9. 149
  10. 150
  11. 151

    Magnetic Resonance Image-Guided Biopsies with a High Detection Rate of Prostate Cancer by Dirk G. Engehausen, Karl Engelhard, Siegfried A. Schwab, Michael Uder, Sven Wach, Bernd Wullich, F. Steffen Krause

    Published 2012-01-01
    “…Ninety-six men with suspected prostate cancer underwent MRI-guided prostate biopsies under real-time imaging control in supine position. …”
    Get full text
    Article
  12. 152

    Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia by Wei Jin, Xiang Fei, Xia Wang, Fangjie Chen, Yan Song

    Published 2020-01-01
    “…Identifying microRNAs (miRNAs) in subjects’ blood with various malignancies means that they can serve as novel biomarkers for prostate cancer (PCa) diagnosis. This study analyzed serum-circulating miRNAs as a noninvasive biomarker in subjects with PCa and subjects with benign prostatic hyperplasia (BPH). …”
    Get full text
    Article
  13. 153
  14. 154

    Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer by Kuang Youlin, Zhang Li, Weng Xiaodong, Liu Xiuheng, Zhu Hengchen

    Published 2012-01-01
    “…These results suggest that combining activation of 4-1BB and blockade of CTLA-4 may offer a new strategy for prostate cancer immunotherapy.…”
    Get full text
    Article
  15. 155

    Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel by Keith L. Davis, Benjamin Gutierrez, Teresa Zyczynski, James A. Kaye

    Published 2015-01-01
    “…**Background:** Docetaxel has been a standard of care for castration-resistant prostate cancer (CRPC) in the United States since 2004, yet little has been reported on its patterns of use in routine practice. …”
    Get full text
    Article
  16. 156

    AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer by Jiawei Zhang, Feng Ding, Yitian Guo, Xiaoying Wei, Jibo Jing, Feng Xu, Huixing Chen, Zhongying Guo, Zonghao You, Baotai Liang, Ming Chen, Dongfang Jiang, Xiaobing Niu, Xiangxue Wang, Yifeng Xue

    Published 2025-02-01
    “…Abstract Biochemical recurrence (BCR) of prostate cancer (PCa) negatively impacts patients’ post-surgery quality of life, and the traditional predictive models have shown limited accuracy. …”
    Get full text
    Article
  17. 157

    Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy by Warlick CA, Spilseth BD, Dixon CM

    Published 2025-02-01
    “…It is possible to successfully retreat residual disease or new lesions identified on surveillance with only transient mild to moderate adverse events and acceptable oncologic outcomes offering a new management strategy for localized prostate cancer.Plain Language Summary: Treatment decisions for men with localized prostate cancer (PCa) are determined with consideration of multiple factors including, disease risk, co-morbidities, estimated life-expectancy and each patient’s preferences. …”
    Get full text
    Article
  18. 158

    Mesenchymal stromal cell exosomes for drug delivery of prostate cancer treatments: a review by Chengran Wang, Yanshuo Feng, Xinao Rong, Jingguo Yan, Baisong Lv, Hongyu Jiang, Lian Duan, Jinlan Jiang

    Published 2025-01-01
    “…Abstract Interest in prostate cancer as a research topic has gradually increased. …”
    Get full text
    Article
  19. 159

    Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer by M. Kamrava, Kwong Y. Tsang, R. A. Madan, A. Kaushal, C. N. Coleman, J. Gulley

    Published 2009-01-01
    “…We describe a patient with node positive prostate cancer treated with radiation, androgen deprivation, and immunotherapy with long-term overall survival and PSA control. …”
    Get full text
    Article
  20. 160

    Prostate Cancer Susceptibility Loci Identified in GATA2 and ZMIZ1 in Chinese Population by Hui-Jing Zhang, Zhongyuan Liu, Liang Kan

    Published 2022-01-01
    “…Common genetic risk variants for prostate cancer (PCa) have been identified at approximately 170 loci using genome-wide association studies (GWAS), most of which were identified in European populations. …”
    Get full text
    Article